The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Cyber stalkers and scammers rely on careless posts and lax security. Here are the key ways to keep your personal information private.
After years of stalking, Kerry Daynes found her pet dead in a twisted position and the message "Jill Dando" scrawled on her home fence.
The issue has been an elephant in the room for many years, and it's always been considered distasteful to debate the matter.